Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05012813 · ClinicalTrials.gov registry record · NA
Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer
A NA study, sponsored by OHSU Knight Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT05012813 is a NA study that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 28 participants.
The verdict
NCT05012813, a NA study, has completed, sponsored by OHSU Knight Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
This clinical trial studies the feasibility of simulating forest therapy using humidified wood or fragrant oils, in improving immune cells, like natural killer cells, number and activity, and their downstream proteins, perforin and granulysin in patients with stage I-III breast or prostate cancer who completed chemo- and/or radiation therapy. The knowledge gained from this study may help cancer patients who have compromised immune systems and who also cannot participate in outdoor activities like exercise or forest walks.
Interventions
- OTHER Aromatherapy with Essential Oils
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2022-07-19 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05012813
The ClinicalTrials.gov registry entry for NCT05012813 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Aromatherapy with Essential Oils is the first listed.
NCT05012813 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05012813 about?
NCT05012813 is a clinical study titled "Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer". This clinical trial studies the feasibility of simulating forest therapy using humidified wood or fragrant oils, in improving immune cells, like natural killer cells, number and activity, and their downstream proteins, perforin and granulysin in patients with stage I-III breast or prostate cancer wh...
What is the current status of trial NCT05012813?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2022-07-19. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT05012813?
The interventions under investigation include: Aromatherapy with Essential Oils (OTHER).
Who is sponsoring clinical trial NCT05012813?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.